IGF1R and neoplasm: Integrin inhibitors downregulate the expression of growth factor receptors that promotes tumor growth and cell proliferation (e.g., insulin-like growth factor: IGF-IR) or mutations in tumor suppressor genes that regulates cell migration on integrins (e.g., Phosphatase and tensin homolog: PTEN), among others [1,4].